Review



pp2ac  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Cell Signaling Technology Inc pp2ac
    IL-17A induces p53, PAI-1, Cav1 and apoptosis, and CSP or CSP7 inhibits IL-17A-induced apoptosis in AECs. ( A ) AECs isolated from uninjured WT and p53 −/− mice were treated with IL-17A (0–100 ng/mL) for 24 h, and the lysates were immunoblotted for p53, PAI-1, Cl./Cas-3 and β-actin. ( B ) WT mice received saline or IL-17A intranasally (0–3 μg in 50 μL saline), as previously described . AECs were isolated 24 h later, and lysates were immunoblotted for p53 and Cl./Cas-3 and β-actin. ( C ) WT mice were exposed to saline or IL-17A (1 μg), as described in ( B ). Lysates of AECs isolated 24 h after treatment with IL-17A were immunoblotted for ACp53, p53, Sirt1, Cav1 and apoptosis. ( D ) AECs isolated from WT mice were treated with PBS or IL-17A (100 ng/mL). Two hours later, IL-17A-stimulated cells were treated with or without CSP or CP (10 µM) and analyzed for p53, PAI-1 and apoptosis by Western blotting (WB). ( E ) AECs isolated from WT mice exposed to IL-17A (100 ng/mL) were treated with CSP, its overlapping deletion fragments, or control peptide (CP) for 24 h in vitro. The lysates were analyzed for ACp53, p53, PAI-1, Sirt1 and Cl. Cas-3 by WB. ( F ) miR-34a fl/fl mice and miR-34acKO mice lacking miR-34a in AECs were exposed to IL-17A (1 μg) with or without CSP7 or CP. Control mice were exposed to saline. Lysates from AECs extracted from these mice were analyzed for p53, PAI-1, Sirt1, Cav1 and apoptosis by WB. ( G ) Lung homogenates or lysates of AECs extracted from WT mice exposed to IL-17A with or without CSP7 or CP were subjected to WB for <t>PP2Ac,</t> pATM and ATM kinase. ( H ) Lung homogenates of IL-17A-exposed mice treated with or without CSP7 or CP were immunoprecipitated (IP) using anti-Cav1 antibody and immunoblotted for p53, mdm2, and PP2Ac. ( I ) Lung homogenates of WT mice exposed to saline or IL-17A with or without CSP7 were analyzed for MPO activity.
    Pp2ac, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 157 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/2259s/pmc12940268-16-2-4?v=Cell+Signaling+Technology+Inc
    Average 94 stars, based on 157 article reviews
    pp2ac - by Bioz Stars, 2026-07
    94/100 stars

    Images

    1) Product Images from "Interleukin-17A Orchestrates Lung Injury and Remodeling Through p53 and uPA System Crosstalk"

    Article Title: Interleukin-17A Orchestrates Lung Injury and Remodeling Through p53 and uPA System Crosstalk

    Journal: International Journal of Molecular Sciences

    doi: 10.3390/ijms27041841

    IL-17A induces p53, PAI-1, Cav1 and apoptosis, and CSP or CSP7 inhibits IL-17A-induced apoptosis in AECs. ( A ) AECs isolated from uninjured WT and p53 −/− mice were treated with IL-17A (0–100 ng/mL) for 24 h, and the lysates were immunoblotted for p53, PAI-1, Cl./Cas-3 and β-actin. ( B ) WT mice received saline or IL-17A intranasally (0–3 μg in 50 μL saline), as previously described . AECs were isolated 24 h later, and lysates were immunoblotted for p53 and Cl./Cas-3 and β-actin. ( C ) WT mice were exposed to saline or IL-17A (1 μg), as described in ( B ). Lysates of AECs isolated 24 h after treatment with IL-17A were immunoblotted for ACp53, p53, Sirt1, Cav1 and apoptosis. ( D ) AECs isolated from WT mice were treated with PBS or IL-17A (100 ng/mL). Two hours later, IL-17A-stimulated cells were treated with or without CSP or CP (10 µM) and analyzed for p53, PAI-1 and apoptosis by Western blotting (WB). ( E ) AECs isolated from WT mice exposed to IL-17A (100 ng/mL) were treated with CSP, its overlapping deletion fragments, or control peptide (CP) for 24 h in vitro. The lysates were analyzed for ACp53, p53, PAI-1, Sirt1 and Cl. Cas-3 by WB. ( F ) miR-34a fl/fl mice and miR-34acKO mice lacking miR-34a in AECs were exposed to IL-17A (1 μg) with or without CSP7 or CP. Control mice were exposed to saline. Lysates from AECs extracted from these mice were analyzed for p53, PAI-1, Sirt1, Cav1 and apoptosis by WB. ( G ) Lung homogenates or lysates of AECs extracted from WT mice exposed to IL-17A with or without CSP7 or CP were subjected to WB for PP2Ac, pATM and ATM kinase. ( H ) Lung homogenates of IL-17A-exposed mice treated with or without CSP7 or CP were immunoprecipitated (IP) using anti-Cav1 antibody and immunoblotted for p53, mdm2, and PP2Ac. ( I ) Lung homogenates of WT mice exposed to saline or IL-17A with or without CSP7 were analyzed for MPO activity.
    Figure Legend Snippet: IL-17A induces p53, PAI-1, Cav1 and apoptosis, and CSP or CSP7 inhibits IL-17A-induced apoptosis in AECs. ( A ) AECs isolated from uninjured WT and p53 −/− mice were treated with IL-17A (0–100 ng/mL) for 24 h, and the lysates were immunoblotted for p53, PAI-1, Cl./Cas-3 and β-actin. ( B ) WT mice received saline or IL-17A intranasally (0–3 μg in 50 μL saline), as previously described . AECs were isolated 24 h later, and lysates were immunoblotted for p53 and Cl./Cas-3 and β-actin. ( C ) WT mice were exposed to saline or IL-17A (1 μg), as described in ( B ). Lysates of AECs isolated 24 h after treatment with IL-17A were immunoblotted for ACp53, p53, Sirt1, Cav1 and apoptosis. ( D ) AECs isolated from WT mice were treated with PBS or IL-17A (100 ng/mL). Two hours later, IL-17A-stimulated cells were treated with or without CSP or CP (10 µM) and analyzed for p53, PAI-1 and apoptosis by Western blotting (WB). ( E ) AECs isolated from WT mice exposed to IL-17A (100 ng/mL) were treated with CSP, its overlapping deletion fragments, or control peptide (CP) for 24 h in vitro. The lysates were analyzed for ACp53, p53, PAI-1, Sirt1 and Cl. Cas-3 by WB. ( F ) miR-34a fl/fl mice and miR-34acKO mice lacking miR-34a in AECs were exposed to IL-17A (1 μg) with or without CSP7 or CP. Control mice were exposed to saline. Lysates from AECs extracted from these mice were analyzed for p53, PAI-1, Sirt1, Cav1 and apoptosis by WB. ( G ) Lung homogenates or lysates of AECs extracted from WT mice exposed to IL-17A with or without CSP7 or CP were subjected to WB for PP2Ac, pATM and ATM kinase. ( H ) Lung homogenates of IL-17A-exposed mice treated with or without CSP7 or CP were immunoprecipitated (IP) using anti-Cav1 antibody and immunoblotted for p53, mdm2, and PP2Ac. ( I ) Lung homogenates of WT mice exposed to saline or IL-17A with or without CSP7 were analyzed for MPO activity.

    Techniques Used: Isolation, Saline, Western Blot, Control, In Vitro, Immunoprecipitation, Activity Assay



    Similar Products

    rat osteoblasts  (Cell Applications Inc)
    93
    Cell Applications Inc rat osteoblasts
    Rat Osteoblasts, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/2259s/pm40996661-77-16-38?v=Cell+Applications+Inc
    Average 93 stars, based on 1 article reviews
    rat osteoblasts - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    pp2ac  (Cell Signaling Technology Inc)
    94
    Cell Signaling Technology Inc pp2ac
    IL-17A induces p53, PAI-1, Cav1 and apoptosis, and CSP or CSP7 inhibits IL-17A-induced apoptosis in AECs. ( A ) AECs isolated from uninjured WT and p53 −/− mice were treated with IL-17A (0–100 ng/mL) for 24 h, and the lysates were immunoblotted for p53, PAI-1, Cl./Cas-3 and β-actin. ( B ) WT mice received saline or IL-17A intranasally (0–3 μg in 50 μL saline), as previously described . AECs were isolated 24 h later, and lysates were immunoblotted for p53 and Cl./Cas-3 and β-actin. ( C ) WT mice were exposed to saline or IL-17A (1 μg), as described in ( B ). Lysates of AECs isolated 24 h after treatment with IL-17A were immunoblotted for ACp53, p53, Sirt1, Cav1 and apoptosis. ( D ) AECs isolated from WT mice were treated with PBS or IL-17A (100 ng/mL). Two hours later, IL-17A-stimulated cells were treated with or without CSP or CP (10 µM) and analyzed for p53, PAI-1 and apoptosis by Western blotting (WB). ( E ) AECs isolated from WT mice exposed to IL-17A (100 ng/mL) were treated with CSP, its overlapping deletion fragments, or control peptide (CP) for 24 h in vitro. The lysates were analyzed for ACp53, p53, PAI-1, Sirt1 and Cl. Cas-3 by WB. ( F ) miR-34a fl/fl mice and miR-34acKO mice lacking miR-34a in AECs were exposed to IL-17A (1 μg) with or without CSP7 or CP. Control mice were exposed to saline. Lysates from AECs extracted from these mice were analyzed for p53, PAI-1, Sirt1, Cav1 and apoptosis by WB. ( G ) Lung homogenates or lysates of AECs extracted from WT mice exposed to IL-17A with or without CSP7 or CP were subjected to WB for <t>PP2Ac,</t> pATM and ATM kinase. ( H ) Lung homogenates of IL-17A-exposed mice treated with or without CSP7 or CP were immunoprecipitated (IP) using anti-Cav1 antibody and immunoblotted for p53, mdm2, and PP2Ac. ( I ) Lung homogenates of WT mice exposed to saline or IL-17A with or without CSP7 were analyzed for MPO activity.
    Pp2ac, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/2259s/pmc12940268-16-2-4?v=Cell+Signaling+Technology+Inc
    Average 94 stars, based on 1 article reviews
    pp2ac - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier
    2259s  (Cell Signaling Technology Inc)
    94
    Cell Signaling Technology Inc 2259s
    IL-17A induces p53, PAI-1, Cav1 and apoptosis, and CSP or CSP7 inhibits IL-17A-induced apoptosis in AECs. ( A ) AECs isolated from uninjured WT and p53 −/− mice were treated with IL-17A (0–100 ng/mL) for 24 h, and the lysates were immunoblotted for p53, PAI-1, Cl./Cas-3 and β-actin. ( B ) WT mice received saline or IL-17A intranasally (0–3 μg in 50 μL saline), as previously described . AECs were isolated 24 h later, and lysates were immunoblotted for p53 and Cl./Cas-3 and β-actin. ( C ) WT mice were exposed to saline or IL-17A (1 μg), as described in ( B ). Lysates of AECs isolated 24 h after treatment with IL-17A were immunoblotted for ACp53, p53, Sirt1, Cav1 and apoptosis. ( D ) AECs isolated from WT mice were treated with PBS or IL-17A (100 ng/mL). Two hours later, IL-17A-stimulated cells were treated with or without CSP or CP (10 µM) and analyzed for p53, PAI-1 and apoptosis by Western blotting (WB). ( E ) AECs isolated from WT mice exposed to IL-17A (100 ng/mL) were treated with CSP, its overlapping deletion fragments, or control peptide (CP) for 24 h in vitro. The lysates were analyzed for ACp53, p53, PAI-1, Sirt1 and Cl. Cas-3 by WB. ( F ) miR-34a fl/fl mice and miR-34acKO mice lacking miR-34a in AECs were exposed to IL-17A (1 μg) with or without CSP7 or CP. Control mice were exposed to saline. Lysates from AECs extracted from these mice were analyzed for p53, PAI-1, Sirt1, Cav1 and apoptosis by WB. ( G ) Lung homogenates or lysates of AECs extracted from WT mice exposed to IL-17A with or without CSP7 or CP were subjected to WB for <t>PP2Ac,</t> pATM and ATM kinase. ( H ) Lung homogenates of IL-17A-exposed mice treated with or without CSP7 or CP were immunoprecipitated (IP) using anti-Cav1 antibody and immunoblotted for p53, mdm2, and PP2Ac. ( I ) Lung homogenates of WT mice exposed to saline or IL-17A with or without CSP7 were analyzed for MPO activity.
    2259s, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/2259s/pmc12940268-16-6-4?v=Cell+Signaling+Technology+Inc
    Average 94 stars, based on 1 article reviews
    2259s - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier
    raw 264 7 cells  (Santa Cruz Biotechnology)
    93
    Santa Cruz Biotechnology raw 264 7 cells
    IL-17A induces p53, PAI-1, Cav1 and apoptosis, and CSP or CSP7 inhibits IL-17A-induced apoptosis in AECs. ( A ) AECs isolated from uninjured WT and p53 −/− mice were treated with IL-17A (0–100 ng/mL) for 24 h, and the lysates were immunoblotted for p53, PAI-1, Cl./Cas-3 and β-actin. ( B ) WT mice received saline or IL-17A intranasally (0–3 μg in 50 μL saline), as previously described . AECs were isolated 24 h later, and lysates were immunoblotted for p53 and Cl./Cas-3 and β-actin. ( C ) WT mice were exposed to saline or IL-17A (1 μg), as described in ( B ). Lysates of AECs isolated 24 h after treatment with IL-17A were immunoblotted for ACp53, p53, Sirt1, Cav1 and apoptosis. ( D ) AECs isolated from WT mice were treated with PBS or IL-17A (100 ng/mL). Two hours later, IL-17A-stimulated cells were treated with or without CSP or CP (10 µM) and analyzed for p53, PAI-1 and apoptosis by Western blotting (WB). ( E ) AECs isolated from WT mice exposed to IL-17A (100 ng/mL) were treated with CSP, its overlapping deletion fragments, or control peptide (CP) for 24 h in vitro. The lysates were analyzed for ACp53, p53, PAI-1, Sirt1 and Cl. Cas-3 by WB. ( F ) miR-34a fl/fl mice and miR-34acKO mice lacking miR-34a in AECs were exposed to IL-17A (1 μg) with or without CSP7 or CP. Control mice were exposed to saline. Lysates from AECs extracted from these mice were analyzed for p53, PAI-1, Sirt1, Cav1 and apoptosis by WB. ( G ) Lung homogenates or lysates of AECs extracted from WT mice exposed to IL-17A with or without CSP7 or CP were subjected to WB for <t>PP2Ac,</t> pATM and ATM kinase. ( H ) Lung homogenates of IL-17A-exposed mice treated with or without CSP7 or CP were immunoprecipitated (IP) using anti-Cav1 antibody and immunoblotted for p53, mdm2, and PP2Ac. ( I ) Lung homogenates of WT mice exposed to saline or IL-17A with or without CSP7 were analyzed for MPO activity.
    Raw 264 7 Cells, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/2259s/pm41372171-273-13-27?v=Santa+Cruz+Biotechnology
    Average 93 stars, based on 1 article reviews
    raw 264 7 cells - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    rabbit monoclonal anti pp2ac  (Cell Signaling Technology Inc)
    94
    Cell Signaling Technology Inc rabbit monoclonal anti pp2ac
    IL-17A induces p53, PAI-1, Cav1 and apoptosis, and CSP or CSP7 inhibits IL-17A-induced apoptosis in AECs. ( A ) AECs isolated from uninjured WT and p53 −/− mice were treated with IL-17A (0–100 ng/mL) for 24 h, and the lysates were immunoblotted for p53, PAI-1, Cl./Cas-3 and β-actin. ( B ) WT mice received saline or IL-17A intranasally (0–3 μg in 50 μL saline), as previously described . AECs were isolated 24 h later, and lysates were immunoblotted for p53 and Cl./Cas-3 and β-actin. ( C ) WT mice were exposed to saline or IL-17A (1 μg), as described in ( B ). Lysates of AECs isolated 24 h after treatment with IL-17A were immunoblotted for ACp53, p53, Sirt1, Cav1 and apoptosis. ( D ) AECs isolated from WT mice were treated with PBS or IL-17A (100 ng/mL). Two hours later, IL-17A-stimulated cells were treated with or without CSP or CP (10 µM) and analyzed for p53, PAI-1 and apoptosis by Western blotting (WB). ( E ) AECs isolated from WT mice exposed to IL-17A (100 ng/mL) were treated with CSP, its overlapping deletion fragments, or control peptide (CP) for 24 h in vitro. The lysates were analyzed for ACp53, p53, PAI-1, Sirt1 and Cl. Cas-3 by WB. ( F ) miR-34a fl/fl mice and miR-34acKO mice lacking miR-34a in AECs were exposed to IL-17A (1 μg) with or without CSP7 or CP. Control mice were exposed to saline. Lysates from AECs extracted from these mice were analyzed for p53, PAI-1, Sirt1, Cav1 and apoptosis by WB. ( G ) Lung homogenates or lysates of AECs extracted from WT mice exposed to IL-17A with or without CSP7 or CP were subjected to WB for <t>PP2Ac,</t> pATM and ATM kinase. ( H ) Lung homogenates of IL-17A-exposed mice treated with or without CSP7 or CP were immunoprecipitated (IP) using anti-Cav1 antibody and immunoblotted for p53, mdm2, and PP2Ac. ( I ) Lung homogenates of WT mice exposed to saline or IL-17A with or without CSP7 were analyzed for MPO activity.
    Rabbit Monoclonal Anti Pp2ac, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/2259s/pmc12780141-722-94-97?v=Cell+Signaling+Technology+Inc
    Average 94 stars, based on 1 article reviews
    rabbit monoclonal anti pp2ac - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier
    anti pp2a c subunit antibody  (Cell Signaling Technology Inc)
    94
    Cell Signaling Technology Inc anti pp2a c subunit antibody
    IL-17A induces p53, PAI-1, Cav1 and apoptosis, and CSP or CSP7 inhibits IL-17A-induced apoptosis in AECs. ( A ) AECs isolated from uninjured WT and p53 −/− mice were treated with IL-17A (0–100 ng/mL) for 24 h, and the lysates were immunoblotted for p53, PAI-1, Cl./Cas-3 and β-actin. ( B ) WT mice received saline or IL-17A intranasally (0–3 μg in 50 μL saline), as previously described . AECs were isolated 24 h later, and lysates were immunoblotted for p53 and Cl./Cas-3 and β-actin. ( C ) WT mice were exposed to saline or IL-17A (1 μg), as described in ( B ). Lysates of AECs isolated 24 h after treatment with IL-17A were immunoblotted for ACp53, p53, Sirt1, Cav1 and apoptosis. ( D ) AECs isolated from WT mice were treated with PBS or IL-17A (100 ng/mL). Two hours later, IL-17A-stimulated cells were treated with or without CSP or CP (10 µM) and analyzed for p53, PAI-1 and apoptosis by Western blotting (WB). ( E ) AECs isolated from WT mice exposed to IL-17A (100 ng/mL) were treated with CSP, its overlapping deletion fragments, or control peptide (CP) for 24 h in vitro. The lysates were analyzed for ACp53, p53, PAI-1, Sirt1 and Cl. Cas-3 by WB. ( F ) miR-34a fl/fl mice and miR-34acKO mice lacking miR-34a in AECs were exposed to IL-17A (1 μg) with or without CSP7 or CP. Control mice were exposed to saline. Lysates from AECs extracted from these mice were analyzed for p53, PAI-1, Sirt1, Cav1 and apoptosis by WB. ( G ) Lung homogenates or lysates of AECs extracted from WT mice exposed to IL-17A with or without CSP7 or CP were subjected to WB for <t>PP2Ac,</t> pATM and ATM kinase. ( H ) Lung homogenates of IL-17A-exposed mice treated with or without CSP7 or CP were immunoprecipitated (IP) using anti-Cav1 antibody and immunoblotted for p53, mdm2, and PP2Ac. ( I ) Lung homogenates of WT mice exposed to saline or IL-17A with or without CSP7 were analyzed for MPO activity.
    Anti Pp2a C Subunit Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/2259s/bio_rxiv__2025__09__04__674365-264-20-33?v=Cell+Signaling+Technology+Inc
    Average 94 stars, based on 1 article reviews
    anti pp2a c subunit antibody - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier
    detailed statistical analysis  (Cell Signaling Technology Inc)
    94
    Cell Signaling Technology Inc detailed statistical analysis
    IL-17A induces p53, PAI-1, Cav1 and apoptosis, and CSP or CSP7 inhibits IL-17A-induced apoptosis in AECs. ( A ) AECs isolated from uninjured WT and p53 −/− mice were treated with IL-17A (0–100 ng/mL) for 24 h, and the lysates were immunoblotted for p53, PAI-1, Cl./Cas-3 and β-actin. ( B ) WT mice received saline or IL-17A intranasally (0–3 μg in 50 μL saline), as previously described . AECs were isolated 24 h later, and lysates were immunoblotted for p53 and Cl./Cas-3 and β-actin. ( C ) WT mice were exposed to saline or IL-17A (1 μg), as described in ( B ). Lysates of AECs isolated 24 h after treatment with IL-17A were immunoblotted for ACp53, p53, Sirt1, Cav1 and apoptosis. ( D ) AECs isolated from WT mice were treated with PBS or IL-17A (100 ng/mL). Two hours later, IL-17A-stimulated cells were treated with or without CSP or CP (10 µM) and analyzed for p53, PAI-1 and apoptosis by Western blotting (WB). ( E ) AECs isolated from WT mice exposed to IL-17A (100 ng/mL) were treated with CSP, its overlapping deletion fragments, or control peptide (CP) for 24 h in vitro. The lysates were analyzed for ACp53, p53, PAI-1, Sirt1 and Cl. Cas-3 by WB. ( F ) miR-34a fl/fl mice and miR-34acKO mice lacking miR-34a in AECs were exposed to IL-17A (1 μg) with or without CSP7 or CP. Control mice were exposed to saline. Lysates from AECs extracted from these mice were analyzed for p53, PAI-1, Sirt1, Cav1 and apoptosis by WB. ( G ) Lung homogenates or lysates of AECs extracted from WT mice exposed to IL-17A with or without CSP7 or CP were subjected to WB for <t>PP2Ac,</t> pATM and ATM kinase. ( H ) Lung homogenates of IL-17A-exposed mice treated with or without CSP7 or CP were immunoprecipitated (IP) using anti-Cav1 antibody and immunoblotted for p53, mdm2, and PP2Ac. ( I ) Lung homogenates of WT mice exposed to saline or IL-17A with or without CSP7 were analyzed for MPO activity.
    Detailed Statistical Analysis, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/2259s/us12377074-483-90-85?v=Cell+Signaling+Technology+Inc
    Average 94 stars, based on 1 article reviews
    detailed statistical analysis - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    IL-17A induces p53, PAI-1, Cav1 and apoptosis, and CSP or CSP7 inhibits IL-17A-induced apoptosis in AECs. ( A ) AECs isolated from uninjured WT and p53 −/− mice were treated with IL-17A (0–100 ng/mL) for 24 h, and the lysates were immunoblotted for p53, PAI-1, Cl./Cas-3 and β-actin. ( B ) WT mice received saline or IL-17A intranasally (0–3 μg in 50 μL saline), as previously described . AECs were isolated 24 h later, and lysates were immunoblotted for p53 and Cl./Cas-3 and β-actin. ( C ) WT mice were exposed to saline or IL-17A (1 μg), as described in ( B ). Lysates of AECs isolated 24 h after treatment with IL-17A were immunoblotted for ACp53, p53, Sirt1, Cav1 and apoptosis. ( D ) AECs isolated from WT mice were treated with PBS or IL-17A (100 ng/mL). Two hours later, IL-17A-stimulated cells were treated with or without CSP or CP (10 µM) and analyzed for p53, PAI-1 and apoptosis by Western blotting (WB). ( E ) AECs isolated from WT mice exposed to IL-17A (100 ng/mL) were treated with CSP, its overlapping deletion fragments, or control peptide (CP) for 24 h in vitro. The lysates were analyzed for ACp53, p53, PAI-1, Sirt1 and Cl. Cas-3 by WB. ( F ) miR-34a fl/fl mice and miR-34acKO mice lacking miR-34a in AECs were exposed to IL-17A (1 μg) with or without CSP7 or CP. Control mice were exposed to saline. Lysates from AECs extracted from these mice were analyzed for p53, PAI-1, Sirt1, Cav1 and apoptosis by WB. ( G ) Lung homogenates or lysates of AECs extracted from WT mice exposed to IL-17A with or without CSP7 or CP were subjected to WB for PP2Ac, pATM and ATM kinase. ( H ) Lung homogenates of IL-17A-exposed mice treated with or without CSP7 or CP were immunoprecipitated (IP) using anti-Cav1 antibody and immunoblotted for p53, mdm2, and PP2Ac. ( I ) Lung homogenates of WT mice exposed to saline or IL-17A with or without CSP7 were analyzed for MPO activity.

    Journal: International Journal of Molecular Sciences

    Article Title: Interleukin-17A Orchestrates Lung Injury and Remodeling Through p53 and uPA System Crosstalk

    doi: 10.3390/ijms27041841

    Figure Lengend Snippet: IL-17A induces p53, PAI-1, Cav1 and apoptosis, and CSP or CSP7 inhibits IL-17A-induced apoptosis in AECs. ( A ) AECs isolated from uninjured WT and p53 −/− mice were treated with IL-17A (0–100 ng/mL) for 24 h, and the lysates were immunoblotted for p53, PAI-1, Cl./Cas-3 and β-actin. ( B ) WT mice received saline or IL-17A intranasally (0–3 μg in 50 μL saline), as previously described . AECs were isolated 24 h later, and lysates were immunoblotted for p53 and Cl./Cas-3 and β-actin. ( C ) WT mice were exposed to saline or IL-17A (1 μg), as described in ( B ). Lysates of AECs isolated 24 h after treatment with IL-17A were immunoblotted for ACp53, p53, Sirt1, Cav1 and apoptosis. ( D ) AECs isolated from WT mice were treated with PBS or IL-17A (100 ng/mL). Two hours later, IL-17A-stimulated cells were treated with or without CSP or CP (10 µM) and analyzed for p53, PAI-1 and apoptosis by Western blotting (WB). ( E ) AECs isolated from WT mice exposed to IL-17A (100 ng/mL) were treated with CSP, its overlapping deletion fragments, or control peptide (CP) for 24 h in vitro. The lysates were analyzed for ACp53, p53, PAI-1, Sirt1 and Cl. Cas-3 by WB. ( F ) miR-34a fl/fl mice and miR-34acKO mice lacking miR-34a in AECs were exposed to IL-17A (1 μg) with or without CSP7 or CP. Control mice were exposed to saline. Lysates from AECs extracted from these mice were analyzed for p53, PAI-1, Sirt1, Cav1 and apoptosis by WB. ( G ) Lung homogenates or lysates of AECs extracted from WT mice exposed to IL-17A with or without CSP7 or CP were subjected to WB for PP2Ac, pATM and ATM kinase. ( H ) Lung homogenates of IL-17A-exposed mice treated with or without CSP7 or CP were immunoprecipitated (IP) using anti-Cav1 antibody and immunoblotted for p53, mdm2, and PP2Ac. ( I ) Lung homogenates of WT mice exposed to saline or IL-17A with or without CSP7 were analyzed for MPO activity.

    Article Snippet: 17 , PP2Ac , CST , 2259S , 1:1000 , .

    Techniques: Isolation, Saline, Western Blot, Control, In Vitro, Immunoprecipitation, Activity Assay